Clinical Trial: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease

Study Status: No longer available
Recruit Status: No longer available
Study Type: Expanded Access




Official Title: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease

Brief Summary: This is a single patient compassionate use protocol to determine whether RAVICTI will improve bile flow in a subject who previously tolerated therapy with Buphenyl.